Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2015

01.09.2015 | Clinical Study

Corpus callosum involvement and postoperative outcomes of patients with gliomas

verfasst von: Ko-Ting Chen, Tai-Wei Erich Wu, Chi-Cheng Chuang, Yung-Hsin Hsu, Peng-Wei Hsu, Yin-Cheng Huang, Tzu-Kang Lin, Chen-Nen Chang, Shih-Tseng Lee, Chieh-Tsai Wu, Chen-Kan Tseng, Chun-Chieh Wang, Ping-Ching Pai, Kuo-Chen Wei, Pin-Yuan Chen

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Corpus callosum involvement is associated with poorer survival in high grade glioma (HGG), but the prognostic value in low grade glioma (LGG) is unclear. To determine the prognostic impact of corpus callosum involvement on progression free survival (PFS) and overall survival (OS) in HGG and LGG, the records of 233 glioma patients treated from 2008 to 2011 were retrospectively reviewed. Preoperative magnetic resonance (MR) images were used to identify corpus callosum involvement. Age, sex, preoperative Karnofsky performance scale, postoperative Eastern Cooperative Oncology Group (ECOG) score and extent of resection (EOR) were evaluated with respect to PFS and OS. The incidence of corpus callosum involvement was similar among HGG (14 %) and LGG (14.5 %). Univariate analysis revealed that PFS and OS were significantly shorter in both WHO grade II and grade IV glioma with corpus callosum involvement (both, p < 0.05). Multivariate analysis showed that grade II glioma with corpus callosum involvement have shorter PFS (p = 0.03), while EOR, instead of corpus callosum involvement (p = 0.16), was an independent factor associated with PFS in grade IV glioma (p < 0.05). Corpus callosum involvement was no longer significantly associated with OS after adjusting age, gender, EOR, preoperative and postoperative performance status (p = 0.16, 0.17 and 0.56 in grade II, III and IV gliomas, respectively). Corpus callosum involvement happened in both LGG and HGG, and is associated with lower EOR and higher postoperative ECOG score both in LGG and HGG. Corpus callosum involvement tends to be an independent prognostic factor for PFS in LGG, but not for OS in LGG or in HGG.
Literatur
1.
Zurück zum Zitat Bureau of Health Promotion, Department of Health. (2013) Cancer Registry Annual Report, 2010, Taiwan. Bureau of Health Promotion, Taipei Bureau of Health Promotion, Department of Health. (2013) Cancer Registry Annual Report, 2010, Taiwan. Bureau of Health Promotion, Taipei
2.
Zurück zum Zitat Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG (2010) Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol 12:520–527PubMedCentralCrossRefPubMed Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG (2010) Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol 12:520–527PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Schwartzbaum JA, Fisher JL, Aldape KD, Wrensh M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neuro 2:494–503CrossRef Schwartzbaum JA, Fisher JL, Aldape KD, Wrensh M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neuro 2:494–503CrossRef
5.
Zurück zum Zitat Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3–8CrossRefPubMed Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3–8CrossRefPubMed
6.
Zurück zum Zitat Huang YC, Wei KC, Chang CH et al (2011) A retrospective survey of patients with malignant gliomas treated in the neuro-oncological care system under the universal national health insurance program in Taiwan. J Clin Neurosci 18:784–788CrossRefPubMed Huang YC, Wei KC, Chang CH et al (2011) A retrospective survey of patients with malignant gliomas treated in the neuro-oncological care system under the universal national health insurance program in Taiwan. J Clin Neurosci 18:784–788CrossRefPubMed
7.
8.
Zurück zum Zitat Rees JH, Smirniotopoulos JG, Jones RV, Wong K (1996) Glioblastoma multiforme: radiologic–pathologic correlation. Radiographics 16:1413–1438CrossRefPubMed Rees JH, Smirniotopoulos JG, Jones RV, Wong K (1996) Glioblastoma multiforme: radiologic–pathologic correlation. Radiographics 16:1413–1438CrossRefPubMed
9.
Zurück zum Zitat Bourekas EC, Varakis K, Bruns D et al (2002) Lesions of the corpus callosum: MR imaging and differential considerations in adults and children. AJR Am J Roentgenol 179:251–257CrossRefPubMed Bourekas EC, Varakis K, Bruns D et al (2002) Lesions of the corpus callosum: MR imaging and differential considerations in adults and children. AJR Am J Roentgenol 179:251–257CrossRefPubMed
10.
Zurück zum Zitat Renard D, Castelnovo G, Campello C et al (2014) An MRI review of acquired corpus callosum lesions. J Neurol Neurosurg Psych 85:1041–1048CrossRef Renard D, Castelnovo G, Campello C et al (2014) An MRI review of acquired corpus callosum lesions. J Neurol Neurosurg Psych 85:1041–1048CrossRef
11.
Zurück zum Zitat Monaco EA 3rd, Armah HB, Nikiforova MN, Hamilton RL, Engh JA (2011) Grade II oligodendroglioma localized to the corpus callosum. Brain Tumor Pathol 28:305–309CrossRefPubMed Monaco EA 3rd, Armah HB, Nikiforova MN, Hamilton RL, Engh JA (2011) Grade II oligodendroglioma localized to the corpus callosum. Brain Tumor Pathol 28:305–309CrossRefPubMed
12.
Zurück zum Zitat Steltzer KJ, Sauvé KI, Spence AM, Griffin TW, Berger MS (1997) Corpus callosum involvement as a prognostic factor for patiens with high-grade astrocytoma. Int J Radiat Oncol Biol Phys 38:27–30CrossRefPubMed Steltzer KJ, Sauvé KI, Spence AM, Griffin TW, Berger MS (1997) Corpus callosum involvement as a prognostic factor for patiens with high-grade astrocytoma. Int J Radiat Oncol Biol Phys 38:27–30CrossRefPubMed
13.
Zurück zum Zitat Dziurzynski K, Blas-Boria D, Suki D et al (2012) Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes. J Neurooncol 109:555–563PubMedCentralCrossRefPubMed Dziurzynski K, Blas-Boria D, Suki D et al (2012) Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes. J Neurooncol 109:555–563PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Allahdini F, Amirjamshidi A, Reza-Zarei M, Abdollahi M (2009) Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: dose maximal resection of the tumor lengthen the median survival? World Neurosurg 73:128–134CrossRefPubMed Allahdini F, Amirjamshidi A, Reza-Zarei M, Abdollahi M (2009) Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: dose maximal resection of the tumor lengthen the median survival? World Neurosurg 73:128–134CrossRefPubMed
15.
16.
Zurück zum Zitat Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198CrossRefPubMed Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198CrossRefPubMed
17.
Zurück zum Zitat Sanai N, Berger MS (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753–766CrossRefPubMed Sanai N, Berger MS (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753–766CrossRefPubMed
18.
Zurück zum Zitat Smith JS, Chang EF, Lamborn KR et al (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338–1345CrossRefPubMed Smith JS, Chang EF, Lamborn KR et al (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338–1345CrossRefPubMed
19.
Zurück zum Zitat Gil-Perotin S, Marin-Husstege M, Li J et al (2006) Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. J Neurosci 26:1107–1116CrossRefPubMed Gil-Perotin S, Marin-Husstege M, Li J et al (2006) Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. J Neurosci 26:1107–1116CrossRefPubMed
20.
Zurück zum Zitat Sanai N, Alvarez-Buylla A, Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353:811–822CrossRefPubMed Sanai N, Alvarez-Buylla A, Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353:811–822CrossRefPubMed
21.
Zurück zum Zitat Chaichana K, Parker S, Olivi A, Quinones-Hinojosa A (2010) A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg 112:997–1004CrossRefPubMed Chaichana K, Parker S, Olivi A, Quinones-Hinojosa A (2010) A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg 112:997–1004CrossRefPubMed
22.
Zurück zum Zitat Jafri NF, Clarke JL, Weinberg V, Barani IJ, Cha S (2013) Relationship of glioblastoma multiforme to the subevntricular zone is associated with survival. Neuro Oncol 15:91–96PubMedCentralCrossRefPubMed Jafri NF, Clarke JL, Weinberg V, Barani IJ, Cha S (2013) Relationship of glioblastoma multiforme to the subevntricular zone is associated with survival. Neuro Oncol 15:91–96PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Kellenberg K, Goldmann T, Menke J et al (2013) Glioma infiltration of the corpus callosum: early signs detected by DTI. J Neurooncol 112:217–222CrossRef Kellenberg K, Goldmann T, Menke J et al (2013) Glioma infiltration of the corpus callosum: early signs detected by DTI. J Neurooncol 112:217–222CrossRef
24.
Zurück zum Zitat Bent MJ, Wefel JS, Schiff D et al (2011) Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12:583–593CrossRefPubMed Bent MJ, Wefel JS, Schiff D et al (2011) Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12:583–593CrossRefPubMed
25.
Zurück zum Zitat Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972CrossRefPubMed Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972CrossRefPubMed
Metadaten
Titel
Corpus callosum involvement and postoperative outcomes of patients with gliomas
verfasst von
Ko-Ting Chen
Tai-Wei Erich Wu
Chi-Cheng Chuang
Yung-Hsin Hsu
Peng-Wei Hsu
Yin-Cheng Huang
Tzu-Kang Lin
Chen-Nen Chang
Shih-Tseng Lee
Chieh-Tsai Wu
Chen-Kan Tseng
Chun-Chieh Wang
Ping-Ching Pai
Kuo-Chen Wei
Pin-Yuan Chen
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2015
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-015-1823-0

Weitere Artikel der Ausgabe 2/2015

Journal of Neuro-Oncology 2/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.